Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Use of prescription drug samples and patient assistance programs, and the role of doctor-patient communication.

Gellad WF, Huskamp HA, Li A, Zhang Y, Safran DG, Donohue JM.

J Gen Intern Med. 2011 Dec;26(12):1458-64. doi: 10.1007/s11606-011-1801-y. Epub 2011 Jul 13.

2.

Whom do older adults trust most to provide information about prescription drugs?

Donohue JM, Huskamp HA, Wilson IB, Weissman J.

Am J Geriatr Pharmacother. 2009 Apr;7(2):105-16. doi: 10.1016/j.amjopharm.2009.04.005.

3.

Medicare beneficiaries and free prescription drug samples: a national survey.

Tjia J, Briesacher BA, Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Gurwitz JH.

J Gen Intern Med. 2008 Jun;23(6):709-14. doi: 10.1007/s11606-008-0568-2. Epub 2008 Mar 7.

4.

Physician-patient communication about prescription medication nonadherence: a 50-state study of America's seniors.

Wilson IB, Schoen C, Neuman P, Strollo MK, Rogers WH, Chang H, Safran DG.

J Gen Intern Med. 2007 Jan;22(1):6-12. Epub 2007 Jan 5.

5.

Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population.

Musich S, Cheng Y, Wang SS, Hommer CE, Hawkins K, Yeh CS.

J Gen Intern Med. 2015 Aug;30(8):1208-14. doi: 10.1007/s11606-015-3196-7. Epub 2015 Feb 10.

6.

Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study.

Schmittdiel JA, Steers N, Duru OK, Ettner SL, Brown AF, Fung V, Hsu J, Quiter E, Tseng CW, Mangione CM.

BMC Health Serv Res. 2010 Jun 14;10:164. doi: 10.1186/1472-6963-10-164.

7.

Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.

Blumberg DM, Prager AJ, Liebmann JM.

JAMA Ophthalmol. 2016 Feb;134(2):212-20. doi: 10.1001/jamaophthalmol.2015.5090.

PMID:
26720853
8.

Prevalence and predictors of utilization of community pharmacy generic drug discount programs.

Gatwood J, Tungol A, Truong C, Kucukarslan SN, Erickson SR.

J Manag Care Pharm. 2011 Jul-Aug;17(6):449-55.

9.

Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.

Safran DG, Strollo MK, Guterman S, Li A, Rogers WH, Neuman P.

J Gen Intern Med. 2010 Jan;25(1):10-7. doi: 10.1007/s11606-009-1134-2. Epub 2009 Oct 31.

10.

Impact of the Medicare modernization act on low-income persons.

Havrda DE, Omundsen BA, Bender W, Kirkpatrick MA.

Ann Intern Med. 2005 Oct 18;143(8):600-8.

PMID:
16230727
11.

Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization.

Burley MH, Daratha KB, Tuttle K, White JR Jr, Wilson M, Armstrong K, McPherson S, Selinger S.

J Manag Care Spec Pharm. 2016 Apr;22(4):381-7. doi: 10.18553/jmcp.2016.22.4.381.

12.

Effect of Medicare Part D and insurance type on Medicare beneficiary access to prescription medication and use of prescription cost-saving measures.

Urmie JM, Farris KB, Doucette WR, Goedken AM.

J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):72-81. doi: 10.1331/JAPhA.2011.09239.

PMID:
21247829
13.

Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage.

Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM.

JAMA. 2004 Aug 25;292(8):952-60.

PMID:
15328327
14.

Awareness of pharmaceutical cost-assistance programs among inner-city seniors.

Federman AD, Safran DG, Keyhani S, Cole H, Halm EA, Siu AL.

Am J Geriatr Pharmacother. 2009 Apr;7(2):117-29. doi: 10.1016/j.amjopharm.2009.04.003.

15.

Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs.

Clay P, Vaught E, Glaros A, Mangum S, Hansen D, Lindsey C.

J Manag Care Pharm. 2007 Jul-Aug;13(6):506-14.

16.

Minimizing out-of-pocket prescription drug costs for Medicare beneficiaries: not just 'a drop in the bucket'.

Patel RA, Vo KA, Chu T, Wang K, Lu S, Woelfel JA, Carr-Lopez SM, Galal SM.

J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):604-9. doi: 10.1331/JAPhA.2014.14043. Erratum in: J Am Pharm Assoc (2003). 2015 Jan-Feb;55(1):5.

PMID:
25379981
18.

Self-restriction of medications due to cost in seniors without prescription coverage.

Steinman MA, Sands LP, Covinsky KE.

J Gen Intern Med. 2001 Dec;16(12):793-9.

19.

Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2014 Aug;20(8):862-76.

20.

Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC.

J Manag Care Spec Pharm. 2015 Oct;21(10):956-64.

Supplemental Content

Support Center